Alexion Pharmaceuticals' Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Alexion Pharmaceuticals careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Position Summary This position will be responsible for the coordination and management of strategic R&D sourcing needs in support of Alexion’s current and planned global clinical trials, including vendor identification and selection, Request ...
Posted: August 16, 2019, 7:45 am
Position Summary This position is intended to deliver on the diagnostic efforts being pursued in conjunction with the development and registration of ALXN1840 for Wilson Disease and other copper-related illnesses. In particular, this p...
Posted: August 16, 2019, 7:45 am
This position can be based in New Haven, CT or Boston, MA Principal Responsibilities + Ownership of the Internal, External, and Supplier GMP/GDP audit programs. + Management of all activities related to the successfu...
Posted: August 16, 2019, 7:45 am
Position Summary The Director, Marketing - aHUS, Complement Business Unit US, will be responsible for the development and implementation of broad US strategic and tactical marketing plans and develop promotional materials to support exec...
Posted: August 15, 2019, 2:49 am
Position Summary The Strategy & Planning Specialist is responsible for providing a wide range of project, programmatic, and logistical support for the Strategy, Planning & Systems Team and the Boston Site Leader. Reporting to the Head of...
Posted: August 14, 2019, 7:18 am

Viewing page 2 of 34|Previous Page|Next Page

  Newsfeed | Subscribe  

You’ve got to feel for Alexion Pharmaceuticals shareholders this week. The company, maker of the rare-disease drug Soliris, put up strong numbers in its earnings report on Wednesday, and on Thursday ...
Posted: July 25, 2019, 7:38 am
Alexion Pharmaceuticals (NASDAQ:ALXN) gave investors a lot to like when it announced its first-quarter results in April. Revenue increased by 23% year over year, while adjusted earnings were up by 42% ...
Posted: July 24, 2019, 12:02 pm
Good morning, and welcome to the Alexion Pharmaceuticals Incorporated Conference Call to discuss Second Quarter 2019 Financial Results. Today's call is being recorded. For opening remarks and ...
Posted: July 24, 2019, 9:26 am
The following slide deck was published by Alexion Pharmaceuticals, Inc. in conjunction with their 2019 Q2 earnings call. Download PDF 135 Click to enlarge Notes: ...
Posted: July 24, 2019, 7:24 am
BOSTON (AP) _ Alexion Pharmaceuticals Inc. (ALXN) on Wednesday reported second-quarter net income of $459.8 million, after reporting a loss in the same period a year earlier. The Boston-based company ...
Posted: July 24, 2019, 3:54 am

Viewing page 2 of 2|Previous Page